Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus

Journal of Crohn's and Colitis

Volumn 7, Issue 10, 2013, Pages 803-811

  Fukuchi, Takumi ^a   Nakase, Hiroshi ^b   Matsuura, Minoru ^b   Yoshino, Takuya ^b   Toyonaga, Takahiko ^b   Ohmori, Katsuyuki ^b   Ubukata, Satoshi ^a   Ueda, Aya ^a   Eguchi, Takaaki ^a   Yamashita, Hiroshi ^a   Ito, Dai ^a   Ashida, Kiyoshi ^a  

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cytomegalovirus; Granulocyte and monocyte adsorptive apheresis; Ulcerative colitis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COLON BIOPSY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS; HEALING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENSIVE CARE; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; THERAPY EFFECT; TREATMENT DURATION; ULCERATIVE COLITIS; VIRAL CLEARANCE; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; COLITIS, ULCERATIVE; COLON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GRANULOCYTES; HUMANS; INTESTINAL MUCOSA; LEUKAPHERESIS; MALE; MONOCYTES; VIRUS ACTIVATION; WOUND HEALING;

EID: 84884139927     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.12.003     Document Type: Article

References (35)

1. McGavran M.H., Smith M.G. Ultrastructural, cytochemical, and microchemical observations on cytomegalovirus (salivary gland virus) infection of human cells in tissue culture. Exp Mol Pathol 1965, 76:1-10.
2. Pass R.F. Epidemiology and transmission of cytomegalovirus. J Infect Dis 1985, 152:243-248.
3. Goodgame R.W. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993, 119:924-935.
4. Rahier J.F., Ben-Horin S., Chowers Y., Conlon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3:47-91.
5. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol 2009, 22:76-98.
6. Gandhi M.K., Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004, 4:725-738.
7. Tanaka N., Kimura H., Iida K., Saito Y., Tsuge I., Yoshimi A., et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 2000, 60:455-462.
8. Nakase H., Matsumura K., Yoshino T., Chiba T. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2008, 43:735-740.
9. Nakase H., Yoshino T., Ueno S., Uza N., Mikami S., Matsuura M., et al. Importance of early detection of cytomegalovirus infection in refractory inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:364.
10. Vega R., Bertrán X., Menacho M., Domènech E., Moreno de Vega V., Hombrados M., et al. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999, 94:1053-1056.
11. Cottone M., Pietrosi G., Martorana G., Casà A., Pecoraro G., Oliva L., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001, 96:773-775.
12. Papadakis K.A., Tung J.K., Binder S.W., Kam L.Y., Abreu M.T., Targan S.R., et al. Outcome of cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2137-2142.
13. Yoshino T., Nakase H., Ueno S., Uza N., Inoue S., Mikami S., et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007, 13:1516-1521.
14. Roblin X., Pillet S., Oussalah A., Berthelot P., Del Tedesco E., Phelip J.M., et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011, 106:2001-2008.
15. Shimoyama T., Sawada K., Hiwatashi N., Sawada T., Matsueda K., Munakata A., et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001, 16:1-9.
16. Saniabadi A.R., Hanai H., Takeuchi K., Umemura K., Adachi T., Shima C., et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory disease associated with leucocytes. Ther Apher Dial 2003, 7:48-59.
17. Hanai H., Watanabe F., Takeuchi K., Iida T., Yamada M., Iwaoka Y., et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003, 1:28-35.
18. Sakuraba A., Motoya S., Watanabe K., Nishishita M., Kanke K., Matsui T., et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009, 104:2990-2995.
19. Fukuchi T., Nakase H., Ito D., Yamashita H., Matsuura M., Nagatani Y., et al. Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive apheresis in active ulcerative colitis patients without concomitant corticosteroid therapy. Aliment Pharmacol Ther 2011, 34:583-585.
20. Yamamoto T., Umegae S., Matzumoto K. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 2006, 12:520-525.
21. Tanaka T., Okanobu H., Yoshimi S., Murakami E., Kogame A., Imagawa H., et al. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Dig Liver Dis 2008, 40:731-736.
22. Yoshino T., Nakase H., Matsuura M., Matsumura K., Honzawa Y., Fukuchi T., et al. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants. Digestion 2011, 84:3-9.
23. Lichtiger S., Present D.H., Kornbluth A., Gelernt I., Bauer J., Galler G., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994, 330:1841-1845.
24. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629.
25. Plachter B., Nordin M., Wirgart B.Z., Mach M., Stein H., Grillner L., et al. The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res 1992, 24:265-276.
26. Chemaly R.F., Yen-Lieberman B., Castilla E.A., Reilly A., Arrigain S., Farver C., et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 2004, 42:2168-2172.
27. Rutgeets P., Sandborn W.J., Feagan B.G., Reinisch W., Olson A., Johanns J., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
28. Kandiel A., Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006, 101:2857-2865.
29. Domènech E., Vega R., Ojanguren I., Hernández A., Garcia-Planella E., Bernal I., et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008, 14:1373-1379.
30. Shiraki K., Ishibashi M., Okuno T., Kokado Y., Takahara S., Yamanishi K., et al. Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus. Transplant Proc 1990, 22:1682-1685.
31. Suzuki H., Kato J., Kuriyama M., Hiraoka S., Kuwaki K., Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010, 16:1245-1251.
32. Wada Y., Matsui T., Matake H., Sakurai T., Yamamoto J., Kikuchi Y., et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003, 46:S59-S65.
33. Kashiwagi N., Sugimura K., Koiwai H., Yamamoto H., Yoshikawa T., Saniabadi A.R., et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002, 6:1334-1341.
34. Kanai T., Hibi T., Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther 2006, 6:453-466.
35. Hanai H. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol 2008, 20:596-600.